Effect of selenite combined with chemotherapeutic agents on the proliferation of human carcinoma cell lines

Biological Trace Element Research

Volumn 99, Issue 1-3, 2004, Pages 17-25

  Schroeder, Claudia P ^a   Goeldner, Eva M ^c   Schulze Forster, Kai ^b   Eickhoff, Christiane A ^b   Holtermann, Peter ^c   Heidecke, Harald ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CellTrend   (Germany)

^c Cefak KG   (Germany)

^d NONE

Author keywords

Chemotherapeutic agents; Human cancer cell lines; Proliferation; Selenium; Sodium selenite

Indexed keywords

ANTINEOPLASTIC AGENT; CEFASEL; CISPLATIN; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; MAFOSFAMIDE; METHOTREXATE; MITOMYCIN C; OXALIPLATIN; SELENITE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; CLINICAL EXAMINATION; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; OBSERVATION;

EID: 3242783310     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/bter:99:1-3:017     Document Type: Article

References (19)

1. G.F. Combs and W.P. Gray, Chemoprotective agents: selenium, Pharmacol. Ther. 79, 179-192 (1998).
2. S.W. May, Selenium-based pharmacological agents: an update. Review, Expert. Opin. Investig. Drugs 11, 1261-1269 (2002).
3. E. Noaman, A.M. Zahran, A.M. Kamal, and M.F. Omran, Vitamin E and selenium administration as a modulator of antioxidant defense system biochemical assessment and modification, Biol. Trace Element Res. 86, 55-64 (2002).
4. K.K. Hamilton, Antioxidant supplements during cancer treatments: where do we stand? Clin. J. Oncol. Nurs. 5, 181-182 (2001).
5. P.B. Caffrey and G.D. Frenkel, Sensitivity of melphalan-resisitant tumors to selenite in vivo. Cancer Lett. 121, 177-180 (1997).
6. D.E. Brash and P.A. Havre, New careers for antioxidants, Proc. Natl. Acad. Sci. USA 99, 13969-13971 (2002).
7. P.B. Caffrey and G.D. Frenkel, Selenite cytotoxicity in drug-resistant and non-resistant ovarian tumor cells, Cancer Res. 52, 4812-4816 (1992).
8. G.D. Frenkel and P.B. Caffrey, A prevention strategy for circumventing drug resistance in cancer chemotherapy, Curr. Pharm. Des. 7, 1595-1614 (2001).
9. D.G. Menter, A.L. Sabichi, and S.M. Lippman, Selenium effects on prostate cell growth, Cancer Epidem. Biomarkers & Prev. 9, 1171-1182 (2000).
10. E.M. van Lieshout, M.P. Ekkel, M.M. Bedaf, W.A. Nijhoff, and W.H. Peters, Effects of dietary anticarcinogens on rat gastrointestinal glutathione peroxidase activity, Oncol. Rep. 5, 959-963 (1998).
11. L. Hosking, R. Whelan, S. Shellard, P. Bedford, and B. Hill, An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumor agents shown by a range of human tumor cell lines, Biochem. Pharmacol. 40, 1833-1842 (1990).
12. J.V. Vadgama, Y. Wu, D. Shen, S. Hsia, and J. Block, Effect of selenium in combination with adriamycin or taxol on several different cancer cells, Anticancer Res. 20, 1391-1414 (2000).
13. P.B. Caffrey and G.D. Frenkel, Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo, Cancer Chemother. Pharmacol. 46, 74-78 (2000).
14. G.S. Baldew, C.J. van den Hamer, G. Los, N.P. Vermeulen, J.J. de Goeij, and J.G. McVie, Selenium-induced protection against cis- diamminedichloroplatinum(II) nephrotoxicity in mice and rats, Cancer Res. 49, 3020-3023 (1989).
15. A. Naganuma, M. Satoh, M. Yokoyama, and N. Imura, Selenium efficiently depressed toxic side effect of cis-diamminedichloroplatinum, Res. Commun. Chem. Pathol. Pharmacol. 42, 127-132 (1983).
16. K. Ohkawa, Y. Tsukada, H. Dohzono, K. Koike, and Y. Terashima, The effects of co-administration of selenium and cisplatin (CDDP) on CDDP-induced toxicity and antitumour activity, Br. J. Cancer 58, 38-41 (1988).
17. N.P. Vermeulen, G.S. Baldew, G. Los, J.G. McVie, and J.J. De Goeij, Reduction of cis-platin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds, Drug Metab. Dispos. 21, 30-36 (1993).
18. Y.J Hu, Y. Chen, Y.Q. Zhang, et al. The protective role of selenium on the toxicity of cis-platin-contained chemotherapy regimen in cancer patients, Biol. Trace Element Res. 56, 331-341 (1997).
19. H. Sundstrom, H. Korpela, E. Sajanti, and A. Kauppila, Supplementation with selenium, vitamin E and their combination in gynaecological cancer during cytotoxic chemotherapy, Carcinogenesis 10, 273-278 (1989).